Kahan, J. P., R. E. Park, L. L. Leape, S. J. Bernstein, L. H. Hilborne, L. Parker, C. J. Kamberg, D. J. Ballard, and R. H. Brooke. 1996. Variations in specialty in physician ratings of the appropriateness and necessity of indications for procedures. Medical Care 34(6):512–523.
KDIGO (Kidney Disease: Improving Global Outcomes). 2010. Clinical practice guidelines. http://www.kdigo.org/clinical_practice_guidelines/guideline_development_process.php (accessed July 16, 2010).
Lavis, J., H. Davies, A. Oxman, J. L. Denis, K. Golden-Biddle, and E. Ferlie. 2005. Towards systematic reviews that inform health care management and policy-making. Journal of Health Services Research & Policy 10(Suppl 1):35–48.
Liberati, A., D. G. Altman, J. Tetzlaff, C. Mulrow, P. C. Gotzsche, J. Ioannidis, M. Clarke, P. J. Devereaux, J. Kleijnen, and D. Moher. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Annals of Internal Medicine 151(4):W1–W30.
McPartland, J. M. 2009. Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship. PLoS One 4(3):e5092.
Moher, D., J. Tetzlaff, A. C. Tricco, M. Sampson, and D. G. Altman. 2007. Epidemiology and reporting characteristics of systematic reviews. PLoS Medicine 4(3): 447–455.
Mulrow, C., P. Langhorne, and J. Grimshaw. 1997. Integrating heterogeneous pieces of evidence in systematic reviews. Annals of Internal Medicine 127(11):989–995.
Murphy, M. K., N. A. Black, D. L. Lamping, C. M. McKee, C. F. Sanderson, J. Askham, and T. Marteur. 1998. Consensus development methods, and their use in clinical guideline development. Health Technology Assessment 2(3):1–88.
NIH (National Institutes of Health). 2010. The NIH Consensus Development Program. Kensington, MD: NIH Consensus Development Program Information Center. http://consensus.nih.gov/aboutcdp.htm (accessed July 16, 2010).
NPAF (National Patient Advocate Foundation). 2011. National Patient Advocate Foundation launches Comparative Effectiveness Research (CER) Database. http://www.npaf. org/images/pdf/news/NPAF_CER_010611.pdf (accessed February 1, 2011).
Oxman, A., and G. Guyatt. 1993. The science of reviewing research. Annals of the New York Academy of Sciences 703:125–133.
Pagliari, C., and J. Grimshaw. 2002. Impact of group structure and process on multidisciplinary evidence-based guideline development: An observational study. Journal of Evaluation in Clinical Practice 8(2):145–153.
PIPC (Partnership to Improve Patient Care). 2011. Welcome to the CER Inventory. http://www.cerinventory.org/ (accessed February 1, 2011).
Richardson, W. S., M. S. Wilson, J. Mishikawa, and R. S. A. Hayward. 1995. The well-built clinical question: A key to evidence based decisions. ACP Journal Club 123(3):A12–A13.
Rockey, S. J., and F. S. Collins. 2010. Managing financial conflict of interest in biomedical research. JAMA 303(23):2400–2402.
Roundtree, A. K., M. A. Kallen, M. A. Lopez-Olivo, B. Kimmel, B. Skidmore, Z. Ortiz, V. Cox, and M. E. Suarez-Almazor. 2008. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: A systematic review. Journal of Clinical Epidemiology 62(2):128–137.
Sacks, H. S., J. Berrier, D. Reitman, V. A. Ancona-Berk, and T. C. Chalmers. 1987. Metaanalyses of randomized controlled trials. New England Journal of Medicine 316(8):450–455.